Price and Chart HIO, page-3840

First 3840 Last

Share
Profile

Follow
treefeller

717 Posts.

192

03/06/22

14:55

Post #: 61806361
Share
Originally posted by That Fundamental Guy: ↑

@jb7 - in case it helps, here are my thoughts as to why there is no institutional shareholders on the share register at this stage:

HIO is outside the ASX 300 - this would preclude many super funds and institutional investments
Whilst many of us believe in the potential of HIO, it has not yet completed the BFS - therefore would be considered too risky for many and probably most institutional investors.
There are no other large shareholders that they could purchase a large volume of shares from.
If there was a fund that wanted to acquire a 5% stake in HIO, this would be very difficult to do on market. Can you imagine what trying to buy 35 million shares on market would do to the price? It would be over $1 before we knew it.
Institutions are not going to buy based on FOMO. They will know that there will be opportunities in the future, such as construction funding, purchase of shares from LDA etc. Even if Bryan was talking about construction funding shares being issued at well over $1, it could be more compelling for them to wait to buy, i.e., buy 35M shares on market now at an unknown price but likely well over $1 with an unknown BFS outcome, or wait until BFS is complete and still pay well over $1 but with a known BFS outcome.
Management have no need at this stage to have one or more large institutions on the share register. It could even be good if there are none on the register when the BFS is completed. Bryan and Glenn may be lining up a large group of institutional investors (a conga line perhaps) that would like to assist with construction funding and then have some sort of a friendly auction to ensure the maximum price paid and minimal dilution.

I am not concerned about there not being any institutions on the share register at this stage. If there were none six months after the BFS I might be a little concerned, but I really can't see that happening. For where we are at now, fully funded for BFS (with access to LDA funding), a very strong and loyal retail base with the capacity to communicate amongst ourselves, growing market awareness and support, I think we are sitting in a very nice position.

Expand

Or maybe, just maybe, they are smart enough to realise there is no port to export product from.
HIO Price at posting: 55.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

HAS

Hastings progressing Yangibana to production with lower costs

There are more pages in this discussion • 3,565 more messages in this thread...

First 3840 Last

Add HIO (ASX) to my watchlist

(20min delay)
Last 2.6¢		Change 0.001(4.00%)		Mkt cap ! $26.42M

Open	High	Low	Value	Volume
2.5¢	2.6¢	2.4¢	$23.35K	923.8K

Buyers (Bids)

No.	Vol.	Price($)
3	234550	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	1238460	3

View Market Depth

No.	Vol.	Price($)
3	234550	0.024
2	225000	0.023
5	207273	0.022
5	277000	0.021
12	2253074	0.020

Price($)	Vol.	No.
0.026	1038460	2
0.028	150000	2
0.029	456257	3
0.030	261358	2
0.031	135000	1

Last trade - 16.10pm 30/09/2024 (20 minute delay)

HIO (ASX) Chart

Price and Chart HIO, page-3840

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Price and Chart HIO, page-3840

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The iron ore comeback: Can it last?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News